Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

Hardingham, Giles E., Bading, Hilmar·2010·Nature Reviews Neuroscience

Cited by (1,001)

Items 301–400 of 1,001

  1. Neurotoxic astrocytes express the d-serine synthesizing enzyme, serine racemase, in Alzheimer's disease
    Darrick T. Balu, Harry Pantazopoulos, Cathy Chia‐Yu Huang, Kevin Muszynski, Theresa L. Harvey, Yota Uno, Jacki M. Rorabaugh, Claire R. Galloway, Christian Alan Botz-Zapp, Sabina Berretta et al. · 2019 · Neurobiology of Disease
  2. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice
    Austen J. Milnerwood, Alexandra M. Kaufman, Marja D. Sepers, Clare M. Gladding, Lily Zhang, Liang Wang, Jing Fan, Ainsley Coquinco, Joy Yi Qiao, Hwan Lee et al. · 2012 · Neurobiology of Disease
  3. Nuclear Calcium Signaling Regulates Nuclear Export of a Subset of Class IIa Histone Deacetylases following Synaptic Activity
    Schlumm, Friederike, Mauceri, Daniela, Freitag, H.Eckehard, Bading, Hilmar · 2013 · Journal of Biological Chemistry
  4. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential
    Chloé Geoffroy, Pierre Paoletti, Laétitia Mony · 2021 · The Journal of Physiology
  5. Synaptic and Extrasynaptic NMDA Receptors Differentially Modulate Neuronal Cyclooxygenase-2 Function, Lipid Peroxidation, and Neuroprotection
    David T. Stark, Nicolas Guillermo Bazan · 2011 · Journal of Neuroscience
  6. Sigma 1 receptor activation regulates brain-derived neurotrophic factor through NR2A-CaMKIV-TORC1 pathway to rescue the impairment of learning and memory induced by brain ischaemia/reperfusion
    Qian Xu, Xuefei Ji, Tianyan Chi, Peng Liu, Ge Jin, Shao-Li Gu, Libo Zou · 2014 · Psychopharmacology
  7. Thioredoxin System Regulation in the Central Nervous System: Experimental Models and Clinical Evidence
    Daniela Silva‐Adaya, María E. Gonsebatt, Jorge Guevara · 2014 · Oxidative Medicine and Cellular Longevity
  8. Prenatal inhibition of the tryptophan–kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus
    Caroline M. Forrest, Omari S. Khalil, Mazura Pisar, Lynda Gail Darlington, Trevor W. Stone · 2013 · Brain Research
  9. Age-Related Changes in d-Aspartate Oxidase Promoter Methylation Control Extracellular d-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging
    Daniela Punzo, Francesco Errico, Luigia Cristino, Silvia Sacchi, Simona Keller, Carmela Belardo, Livio Luongo, Tommaso Nuzzo, Roberta Imperatore, Ermanno Florio et al. · 2016 · Journal of Neuroscience
  10. Danggui-Shaoyao-San: New Hope for Alzheimer's Disease
    Xin Fu, Qiuhong Wang, Zhibin Wang, Haixue Kuang, Pinghui Jiang · 2016 · Aging and Disease
  11. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
    Shuang Chen, Da Xu, Fan Liu, Zhi Hong Fang, Xiufeng Wang, Man Li · 2022 · Frontiers in Molecular Neuroscience
  12. Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
    John Harrison Krystal, Alfred P. Kaye, Sarah Jefferson, Matthew J. Girgenti, Samuel T. Wilkinson, Gerard Sanacora, Irina Esterlis · 2023 · Proceedings of the National Academy of Sciences
  13. NMDA and AMPA Receptors: Development and Status Epilepticus
    Ewa Szczurowska, P. MAREŠ · 2013 · Physiological Research
  14. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK 1/2–CREB–ATF3 signaling pathway
    Fang Wu, Ramiro Echeverry, Jialing Wu, Jie An, Woldeab B. Haile, Deborah S. Cooper, Marcela Catano, Manuel Yepes · 2012 · Molecular and Cellular Neuroscience
  15. Cross-talk and regulation between glutamate and GABAB receptors
    Sriharsha Kantamneni · 2015 · Frontiers in Cellular Neuroscience
  16. Brain energy metabolism in glutamate-receptor activation and excitotoxicity: Role for APC/C-Cdh1 in the balance glycolysis/pentose phosphate pathway
    Patricia Rodriguez‐Rodriguez, Ángeles Almeida, Juan Pedro Bolaños · 2013 · Neurochemistry International
  17. Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex
    Jennifer Stanic, Mario Carta, Ivano Eberini, Silvia Pelucchi, Elena E. Marcello, Armando A. Genazzani, Claudia Racca, Christophe Mulle, Mónica Di Luca, Fabrizio Gardoni · 2015 · Nature Communications
  18. Calcium signalling: A common target in neurological disorders and neurogenesis
    Talita Glaser, Vanessa Fernandes Arnaud-Sampaio, Claudiana Lameu, Henning Ulrich · 2018 · Seminars in Cell and Developmental Biology
  19. Posttranslational modification impact on the mechanism by which amyloid‐β induces synaptic dysfunction
    Katarzyna M. Grochowska, PingAn Yuanxiang, Julia Bär, Rajeev Raman, Gemma Navarro Brugal, Giriraj Sahu, Michaela Schweizer, Arthur F. Bikbaev, Stephan Schilling, Hans‐Ulrich Demuth et al. · 2017 · EMBO Reports
  20. Mitochondrial Abnormalities and Synaptic Damage in Huntington’s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics
    Neha A. Sawant, Hallie Morton, Sudhir Kshirsagar, Arubala P. Reddy, P. Hemachandra Reddy · 2021 · Molecular Neurobiology
  21. Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury
    Ke Lai, Iva Pritišanac, Zhen-Qi Liu, Han-Wei Liu, Li-Na Gong, Mingxian Li, Jian‐Fei Lu, Xin Qi, Tian‐Le Xu, Julie Deborah Forman-Kay et al. · 2024 · Nature
  22. Synapse-to-nucleus signaling
    Toh Hean Ch’ng, Kelsey C. Martin · 2011 · Current Opinion in Neurobiology
  23. NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina
    Ning Bai, Tomomi Aida, Michiko Yanagisawa, Sayaka Katou, Kenji Sakimura, Masayoshi Mishina, Kohichi Tanaka · 2013 · Molecular Brain
  24. Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review
    Karanikas, Evangelos, Daskalakis, Nikolaos P., Agorastos, Agorastos · 2021 · Brain Sciences
  25. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease
    Karim Bordji, Javier Becerril-Ortega, Alain Buisson · 2011 · Reviews in the Neurosciences
  26. Corticostriatal Dysfunction in Huntington’s Disease: The Basics
    Kendra D. Bunner, George V. Rebec · 2016 · Frontiers in Human Neuroscience
  27. Calpain-1 and Calpain-2 in the Brain: New Evidence for a Critical Role of Calpain-2 in Neuronal Death
    Yubin Wang, Yan Liu, Xiaoning Bi, Michel Baudry · 2020 · Cells
  28. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
    Filippo Caraci, Giuseppe Battaglia, Maria Angela Sortino, Simona Federica Spampinato, Gemma Molinaro, Agata Copani, Ferdinando Nicoletti, Valeria Bruno · 2012 · Neurochemistry International
  29. Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives
    Sheshachala Karthik, Lavanya P. Sharma, Janardhanan C. Narayanaswamy · 2020 · Neuropsychiatric Disease and Treatment
  30. Synaptic Dysfunction in Huntington’s Disease: Lessons from Genetic Animal Models
    Carlos Cepeda, Michael S. Levine · 2020 · The Neuroscientist
  31. Revealing the contribution of astrocytes to glutamatergic neuronal transmission
    Ares Orlando Cuellar-Santoyo, Victor Manuel Ruiz-Rodríguez, Teresa Belem Mares-Barbosa, Araceli Patrón‐Soberano, Andrew G. Howe, Diana Patricia Portales‐Pérez, Amaya Miquelajáuregui Graf, Ana María Estrada‐Sánchez · 2023 · Frontiers in Cellular Neuroscience
  32. Neuron-astrocyte omnidirectional signaling in neurological health and disease
    Dhruba Pathak, Krishnan Sriram · 2023 · Frontiers in Molecular Neuroscience
  33. Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses
    Lei Ren, Chunfeng Liu, Kaan Çifcibaşı, Markus Ballmann, Gerhard Rammes, Carmen Mota Reyes, Sergey V. Tokalov, Andreas Klingl, Jennifer Grünert, Keshav Goyal et al. · 2025 · Cancer Cell
  34. Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer’s disease
    Masahiro Okamoto, Jason D. Gray, Chloe S. Larson, Syed Faraz Kazim, Hideaki Soya, Bruce S. McEwen, Ana C. Pereira · 2018 · Translational Psychiatry
  35. Human gestational N‐methyl‐d‐aspartate receptor autoantibodies impair neonatal murine brain function
    B. Jurek, M. Chayka, J. Kreye, K. Lang, Larissa Kraus, P. Fidzinski, Hans-Christian Kornau, Le-Minh Dao, N. Wenke, M. Long et al. · 2019 · Annals of Neurology
  36. Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
    Yating Wang, Xiaole Wang, Sitong Feng, Nai‐Hong Chen, Zhen‐Zhen Wang, Yi Zhang · 2021 · Pharmacological Research
  37. Lurasidone Exerts Antidepressant Properties in the Chronic Mild Stress Model through the Regulation of Synaptic and Neuroplastic Mechanisms in the Rat Prefrontal Cortex
    Alessia Luoni, Flavia Macchi, Mariusz Papp, Raffaella Molteni, Marco Andrea Riva · 2015 · The International Journal of Neuropsychopharmacology
  38. α7 Nicotinic ACh Receptors as a Ligand-Gated Source of Ca2+ Ions: The Search for a Ca2+ Optimum
    Victor V. Uteshev · 2012 · Advances in experimental medicine and biology
  39. Current hypotheses on the mechanisms of alcoholism
    Ryan P. Vetreno, Fulton T. Crews · 2014 · Handbook of clinical neurology
  40. d-Serine, the Shape-Shifting NMDA Receptor Co-agonist
    Joseph T. Coyle, Darrick T. Balu, Herman Wolosker · 2020 · Neurochemical Research
  41. Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
    MaKayla F. Cox, Erin R. Hascup, Andrzej Bartke, Kevin N. Hascup · 2022 · Frontiers in Aging
  42. Surgical Incision-Induced Nociception Causes Cognitive Impairment and Reduction in Synaptic NMDA Receptor 2B in Mice
    Xiaoqin Zhang, Xin Xin, Yuanlin Dong, Yiying Zhang, Buwei Yu, Jianren Mao, Zhongcong Xie · 2013 · Journal of Neuroscience
  43. Impaired glutamate recycling and GluN2B‐mediated neuronal calcium overload in mice lacking TGF‐β1 in the CNS
    Koeglsperger, Thomas, Li, Shaomin, Brenneis, Christian, Saulnier, Jessica L., Mayo, Lior, Carrier, Yijun, Selkoe, Dennis J., Weiner, Howard L. · 2013 · Glia
  44. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity
    Stefanie A. G. Black, Peter K. Stys, Gerald Werner Zamponi, Shigeki Tsutsui · 2014 · Frontiers in Cell and Developmental Biology
  45. Activation of extrasynaptic NMDA receptors induces LTD in rat hippocampal CA1 neurons
    Dan-dan Liu, Qian Yang, Sheng‐Tian Li · 2012 · Brain Research Bulletin
  46. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury
    Denise R. Cook, Amy J. Gleichman, Stephanie A. Cross, Shachee Doshi, Wen‐Zhe Ho, Kelly L. Jordan‐Sciutto, David R. Lynch, Dennis L. Kolson · 2011 · Journal of Neurochemistry
  47. Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
    Michel Baudry · 2019 · Current Neuropharmacology
  48. A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD
    Chadi G. Abdallah, Jeremy D. Coplan, Andrea Parolin Jackowski, João Ricardo Sato, Xiangling Mao, Dikoma C. Shungu, Sanjay J. Mathew · 2012 · European Neuropsychopharmacology
  49. Behavioral and cognitive effects of the N-methyl-d-aspartate receptor co-agonist d-serine in healthy humans: Initial findings
    Raz Levin, Adi Ein Dor-Abarbanel, Shany Edelman, Andrea R. Durrant, Kenji Hashimoto, Daniel C. Javitt, Uriel Heresco‐Levy · 2014 · Journal of Psychiatric Research
  50. NR2A and NR2B subunits differentially mediate MAP kinase signaling and mitochondrial morphology following excitotoxic insult
    Anthony M. Choo, Donna M. Geddes‐Klein, Adam J. Hockenberry, David Scarsella, Mahlet N. Mesfin, Pallab K. Singh, Tapan P. Patel, David F. Meaney · 2012 · Neurochemistry International
  51. Nuclear Calcium Sensors Reveal that Repetition of Trains of Synaptic Stimuli Boosts Nuclear Calcium Signaling in CA1 Pyramidal Neurons
    C. Peter Bengtson, H. Eckehard Freitag, Jan-Marek Weislogel, Hilmar Bading · 2010 · Biophysical Journal
  52. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors
    Flavie Lesept, Arnaud Chevilley, Julie Jézéquel, Laurent Ladépêche, Richard Macrez, Margaux Aimable, Sophie Lenoir, Thomas Bertrand, Laëtitia Rubrecht, Pascale Galéa et al. · 2016 · Cell Death and Disease
  53. NMDA receptor signaling: death or survival?
    Tong Luo, Wei-Hua Wu, Bo-Shiun Chen · 2011 · Frontiers in Biology
  54. Store-Operated Calcium Entry Promotes the Degradation of the Transcription Factor Sp4 in Resting Neurons
    Jasmin Lalonde, Gregory Saia, Grace Gill · 2014 · Science Signaling
  55. Dual action of L-Lactate on the activity of NR2B-containing NMDA receptors: from potentiation to neuroprotection
    Pascal Jourdain, K. Rothenfusser, Carine Benadiba, Igor Allaman, Pierre P. Marquet, Pierre Julius Magistretti · 2018 · Scientific Reports
  56. Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
    Subha Subramanian, Simon Haroutounian, Ben Julian A. Palanca, Eric J. Lenze · 2022 · Journal of the Neurological Sciences
  57. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression
    W.N. Marsden · 2011 · Medical Hypotheses
  58. The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration
    Mark A. Halloran, Sonam Parakh, Julie D. Atkin · 2013 · International Journal of Cell Biology
  59. A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases
    Yunxia Luo, Qi Wang, Yongbin Zhang · 2015 · Journal of Ethnopharmacology
  60. Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices
    Min‐Yu Sun, Yukitoshi Izumi, Ann M. Benz, Charles F. Zorumski, Steven J. Mennerick · 2015 · Journal of Neurophysiology
  61. Postsynaptic Neurotransmitter Receptor Reserve Pools for Synaptic Potentiation
    Matthias Kneussel, Torben Johann Hausrat · 2016 · Trends in Neurosciences
  62. A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
    Júlia Companys‐Alemany, Andreea L. Turcu, Aina Bellver‐Sanchís, Marı́a Isabel Loza, Jose Manuel Brea, Anna Maria Canudas, Rosana Leiva, Santiago Vázquez, Mercè Pallàs, Christian Griñán‐Ferré · 2020 · Pharmaceutics
  63. Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
    Hiroto Takahashi, Peng Xia, Jiankun Cui, Maria V. Talantova, Karthik Bodhinathan, Wenjun Li, Sofiyan Saleem, Emily A. Holland, Gary Tong, Juan Piña-Crespo et al. · 2015 · Scientific Reports
  64. PGC-1α Negatively Regulates Extrasynaptic NMDAR Activity and Excitotoxicity
    Clare A. Puddifoot, Marc‐André Martel, Francesc Xavier Soriano, Alberto Camacho‐Morales, Antonio Vidal‐Puig, David J. A. Wyllie, Giles E. Hardingham · 2012 · Journal of Neuroscience
  65. Cellular calcium signaling in the aging brain
    Chandran Remya, Mantosh Kumar, Lakshmi Kesavan, Reena Sarah Jacob, Sowmya Gunasekaran, Sethu Lakshmi, Chittalakkottu Sadasivan, R.V. Omkumar · 2017 · Journal of Chemical Neuroanatomy
  66. Single-Cell Imaging of Bioenergetic Responses to Neuronal Excitotoxicity and Oxygen and Glucose Deprivation
    Connolly, N. M. C., Dussmann, H., Anilkumar, U., Huber, H. J., Prehn, J. H. M. · 2014 · Journal of Neuroscience
  67. High-frequency head impact causes chronic synaptic adaptation and long-term cognitive impairment in mice
    Stephanie S. Sloley, Bevan S. Main, Charisse N. Winston, Alex C. Harvey, Alice Kaganovich, Holly T. Korthas, Adam Caccavano, David N. Zapple, Jian‐Young Wu, John G. Partridge et al. · 2021 · Nature Communications
  68. The involvement of ERK/CREB/Bcl-2 in depression-like behavior in prenatally stressed offspring rats
    Lixia Guan, Ning Jia, Xiaoyan Zhao, Xiaohua Zhang, Guokui Tang, Li Yang, Hongli Sun, Dan Wang, Qian Su, Qian Song et al. · 2013 · Brain Research Bulletin
  69. Twenty-four hour quantitative-EEG and in-vivo glutamate biosensor detects activity and circadian rhythm dependent biomarkers of pathogenesis in Mecp2 null mice
    Michael V. Johnston, Simon Gashaw Ammanuel, Cliona M. O’Driscoll, Amy W. Wozniak, Sakkubai Naidu, Shilpa D. Kadam · 2014 · Frontiers in Systems Neuroscience
  70. Differential Effects of Synaptic and Extrasynaptic NMDA Receptors on Aβ-Induced Nitric Oxide Production in Cerebrocortical Neurons
    Elena Molokanova, Mohd Waseem Akhtar, Sara Sanz‐Blasco, Shichun Tu, Juan Piña-Crespo, Scott R. McKercher, Stuart A. Lipton · 2014 · Journal of Neuroscience
  71. Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples
    Anastasios Mastrokolias, René Pool, Eleni Mina, Kristina Maria Hettne, Erik van Duijn, Roos C. van der Mast, Gert‐Jan B. van Ommen, Peter A.C. ’t Hoen, Cornelia P. Prehn, Jerzy Adamski et al. · 2016 · Metabolomics
  72. The Role of D-Amino Acids in Alzheimer’s Disease
    Luciano Piubelli, Giulia Murtas, Valentina Rabattoni, Loredano Pollegioni · 2021 · Journal of Alzheimer s Disease
  73. Nuclear Calcium Signaling Controls Methyl-CpG-binding Protein 2 (MeCP2) Phosphorylation on Serine 421 following Synaptic Activity
    Bettina Buchthal, David Lau, Ursula Keller Weiss, Jan-Marek Weislogel, Hilmar Bading · 2012 · Journal of Biological Chemistry
  74. Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: Implications for neuropsychiatric diseases
    Hong Lin, Fu‐Chun Hsu, Bailey H. Baumann, Douglas A. Coulter, David R. Lynch · 2013 · Neurobiology of Disease
  75. ‘SNO’-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders
    Tomohiro Nakamura, Stuart A. Lipton · 2017 · Trends in Endocrinology and Metabolism
  76. Calcium-Dependent Desensitization of NMDA Receptors
    Dmitry A. Sibarov, Sergei M. Antonov · 2018 · Biochemistry (Moscow)
  77. Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease
    Ning Li, Ling Li, Haiming Wu, Heng Zhou · 2019 · Oxidative Medicine and Cellular Longevity
  78. CaMKII versus DAPK1 Binding to GluN2B in Ischemic Neuronal Cell Death after Resuscitation from Cardiac Arrest
    Olivia R. Buonarati, Sarah G. Cook, Dayton J. Goodell, Nicholas E. Chalmers, Nicole L. Rumian, Jonathan E. Tullis, Susana Restrepo, Steven J. Coultrap, Nidia Quillinan, Paco S. Herson et al. · 2020 · Cell Reports
  79. Sigma-1 receptor: a potential therapeutic target for traumatic brain injury
    Shi, Mingming, Chen, Fanglian, Chen, Zhijuan, Yang, Weidong, Yue, Shuyuan, Zhang, Jianning, Chen, Xin · 2021 · Frontiers in Cellular Neuroscience
  80. Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
    María Calvo-Rodríguez, Elizabeth K. Kharitonova, Brian J. Bacskai · 2020 · Cells
  81. NMDARs mediate peripheral and central sensitization contributing to chronic orofacial pain
    Ya-Jing Liu, Yue-Ling Li, Zhong-Han Fang, H. Liao, Yan-Yan Zhang, Jiu Lin, Fei Liu, Jie-Fei Shen · 2022 · Frontiers in Cellular Neuroscience
  82. Astrocytes Modulate a Postsynaptic NMDA–GABAA-Receptor Crosstalk in Hypothalamic Neurosecretory Neurons
    Evgeniy S. Potapenko, Vinicia C. Biancardi, Yiqiang Zhou, Javier Eduardo Stern · 2013 · Journal of Neuroscience
  83. Region- and Activity-Dependent Regulation of Extracellular Glutamate
    Nawrin Ferdous Pinky, Crystal M. Wilkie, Jocelyn R. Barnes, Matthew P. Parsons · 2018 · Journal of Neuroscience
  84. Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory
    Kelvin Chan, Jacquelyn Nestor, Tomas S. Huerta, Noele Certain, Gabrielle R. Moody, Czeslawa Kowal, Patricio T. Huerta, Bruce T. Volpe, Betty Diamond, Lonnie P. Wollmuth · 2020 · Nature Communications
  85. Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury
    Bhattacharjee, Surjyadipta, Jun, Bokkyoo, Belayev, Ludmila, Heap, Jessica, Kautzmann, Marie-Audrey, Obenaus, Andre, Menghani, Hemant, Marcell, Shawn J., Khoutorova, Larissa, Yang, Rong et al. · 2017 · Science Advances
  86. Nanoscale rules governing the organization of glutamate receptors in spine synapses are subunit specific
    Martin Hruska, Rachel E. Cain, Matthew B. Dalva · 2022 · Nature Communications
  87. Novel Insights into Depression and Antidepressants: A Synergy Between Synaptogenesis and Neurogenesis?
    Francis Rodriguez Bambico, Catherine Belzung · 2012 · Current topics in behavioral neurosciences
  88. Bax Regulates Neuronal Ca2+Homeostasis
    Beatrice D’Orsi, Seán M. Kilbride, Gang Chen, Sergio Perez‐Alvarez, Helena P. Bonner, Shona Pfeiffer, Nikolaus Plesnila, Tobías Engel, David Clifford Henshall, Heiko Düßmann et al. · 2015 · Journal of Neuroscience
  89. Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors
    Sumit Barua, Jong Youl Kim, Jae Young Kim, Jae Hwan Kim, Jong Eun Lee · 2019 · Neurochemical Research
  90. Alcohol impairs hippocampal function: From NMDA receptor synaptic transmission to mitochondrial function
    Rodrigo G. Mira, Cheril Tapia‐Rojas, Maria Jose Perez J., Claudia Jara, Erick H. Vergara, Rodrigo A. Quintanilla, Waldo F. Cerpa · 2019 · Drug and Alcohol Dependence
  91. Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
    Jaydeep Roy, Ka Chun Tsui, Jonah Ng, Man‐Lung Fung, Lee Wei Lim · 2021 · International Journal of Molecular Sciences
  92. Chronic Excitotoxin-Induced Axon Degeneration in a Compartmented Neuronal Culture Model
    Katherine A Hosie, Anna Elizabeth King, Catherine A. Blizzard, James Clement Vickers, Tracey C. Dickson · 2012 · ASN NEURO
  93. mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats
    Valentina Sabino, Aditi R. Narayan, Tamara Zeric, Luca Steardo, Pietro Cottone · 2013 · Behavioural Brain Research
  94. Neurotoxic Saboteurs: Straws that Break the Hippo’s (Hippocampus) Back Drive Cognitive Impairment and Alzheimer’s Disease
    Mak Adam Daulatzai · 2013 · Neurotoxicity Research
  95. Inhibition of the Polyamine System Counteracts β-Amyloid Peptide-Induced Memory Impairment in Mice: Involvement of Extrasynaptic NMDA Receptors
    Guilherme M. Gomes, Gerusa Duarte Dalmolin, Julia Bär, Anna Karpova, Carlos Fernando Mello, Michael R. Kreutz, Maribel Antonello Rubin · 2014 · PLoS ONE
  96. Effects of memantine on the excitation-inhibition balance in prefrontal cortex
    Nadezhda V. Povysheva, Jon W. Johnson · 2016 · Neurobiology of Disease
  97. Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
    Yinyi Xiong, Chae‐Seok Lim · 2021 · Brain Sciences
  98. Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
    Manuel Yepes · 2015 · Frontiers in Cellular Neuroscience
  99. Axonopathy in Huntington's disease
    Li, Jia-Yi, Conforti, Laura · 2013 · Experimental Neurology
  100. Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity
    Olayemi Joseph Olajide, Ismail Gbadamosi, Emmanuel Olusola Yawson, Tolulope Timothy Arogundade, Folashade Susan Lewu, Kehinde Yomi Ogunrinola, Oluwaseun Olaniyi Adigun, Olawande Bamisi, Ezra Lambe, Leviticus Oghenevurinrin Arietarhire et al. · 2021 · Journal of Molecular Neuroscience